By Brice Wallace 

Recursion Pharmaceuticals is emphasizing the “tech” in “biotech.”

The Salt Lake City-based company is at the forefront of trying new ways to leverage artificial intelligence, automation and experimental biology to produce data that can eventually lead to the creation of medicines to treat diseases.

The rest of this article is only available to our online subscribers. Please log in, or click here to subscribe.

Pin It